How does a new Covid-19 variant respond to tests?
When a new variant of Covid-19 emerges, it alters the structure of the virus – but does that impact the results of tests?
When a new variant of Covid-19 emerges, it alters the structure of the virus – but does that impact the results of tests?
Speakers emphasised the need for classification and approval of devices, and effective licencing and quality control at BioTrinity 2024.
Global life sciences company Labcorp has announced the first commercially available GFAP blood biomarker test in the US.
The TELE-ACS designed to test SHL Telemedicine’s SmartHeart system was also able to significant drop emergency hospital visits by 41%.
The NAVIGATE-PF study will enrol 30 subjects across Europe with paroxysmal or persistent atrial fibrillation (AF).
Aventa Genomics has launched its next-generation sequencing (NGS) test, Aventa FusionPlus, to identify gene fusions and translocations.
The robotic surgery platform is aimed at speeding up aortic valve replacement surgeries whilst cutting down on staff.
Current North America and Europe market leader drops ventilator product lines, pivots to form Acute Care and Monitoring business.
The automated closed loop system delivered improved glycaemic and patient-reported outcomes versus traditional tech.
Medical devices in Industry 4.0 are providing healthcare providers with greater amounts of data for more accurate diagnostics, but can fourth-generation connectivity keep up?
New research has shown that some companies manipulate the narrative of women’s empowerment to sell AMH tests.